Literature DB >> 20516112

Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate.

Jong Wook Kim1, Seiichi Mori, Joseph R Nevins.   

Abstract

The Myc pathway, often deregulated in cancer, is critical in determining cell fate by coordinating a gene expression program that links the control of cell proliferation with cell fate decisions. As such, precise control of the Myc pathway activity must be achieved to ensure faithful execution of appropriate cellular response and to prevent progressing toward a malignant state. With recent highlighted roles of microRNAs (miRNA) as critical components of gene control, we sought to evaluate the extent to which miRNAs may contribute in the execution of Myc function. Combined analysis of mRNA and miRNA expression profiles reveals an integration whereby the Myc-mediated induction of miRNAs leads to the repression of various mRNAs encoding tumor suppressors that block cell proliferation including p21, p27, and Rb. In addition, the proapoptotic PTEN tumor suppressor gene is also repressed by Myc-induced miRNAs, suggesting that Myc-induced miRNAs contribute to the precise control of a transcriptional program that coordinates the balance of cell proliferation and cell death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516112      PMCID: PMC2888768          DOI: 10.1158/0008-5472.CAN-10-0659

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

Review 1.  The multiple roles of PTEN in tumor suppression.

Authors:  A Di Cristofano; P P Pandolfi
Journal:  Cell       Date:  2000-02-18       Impact factor: 41.582

Review 2.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

3.  Induction of DNA replication in adult rat neurons by deregulation of the retinoblastoma/E2F G1 cell cycle pathway.

Authors:  D S Smith; G Leone; J DeGregori; M N Ahmed; M B Qumsiyeh; J R Nevins
Journal:  Cell Growth Differ       Date:  2000-12

4.  Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.

Authors:  A L Gartel; X Ye; E Goufman; P Shianov; N Hay; F Najmabadi; A L Tyner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

5.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.

Authors:  H A Coller; C Grandori; P Tamayo; T Colbert; E S Lander; R N Eisenman; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

6.  Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.

Authors:  W Yang; J Shen; M Wu; M Arsura; M FitzGerald; Z Suldan; D W Kim; C S Hofmann; S Pianetti; R Romieu-Mourez; L P Freedman; G E Sonenshein
Journal:  Oncogene       Date:  2001-03-29       Impact factor: 9.867

7.  A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.

Authors:  G F Claassen; S R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

8.  A novel transrepression pathway of c-Myc. Recruitment of a transcriptional corepressor complex to c-Myc by MM-1, a c-Myc-binding protein.

Authors:  A Satou; T Taira; S M Iguchi-Ariga; H Ariga
Journal:  J Biol Chem       Date:  2001-10-03       Impact factor: 5.157

9.  Anchorage-independent cell growth signature identifies tumors with metastatic potential.

Authors:  S Mori; J T Chang; E R Andrechek; N Matsumura; T Baba; G Yao; J W Kim; M Gatza; S Murphy; J R Nevins
Journal:  Oncogene       Date:  2009-06-01       Impact factor: 9.867

Review 10.  c-MYC: more than just a matter of life and death.

Authors:  Stella Pelengaris; Mike Khan; Gerard Evan
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

View more
  27 in total

1.  Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.

Authors:  Javeed Iqbal; Yulei Shen; Yanyan Liu; Kai Fu; Elaine S Jaffe; Cuiling Liu; Zhongfeng Liu; Cynthia M Lachel; Karen Deffenbacher; Timothy C Greiner; Julie M Vose; Sharathkumar Bhagavathi; Louis M Staudt; Lisa Rimsza; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger; Timothy W McKeithan; Wing C Chan
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

2.  Genome-Wide Analysis of c-MYC-Regulated mRNAs and miRNAs and c-MYC DNA-Binding by Next-Generation Sequencing.

Authors:  Rene Jackstadt; Markus Kaller; Antje Menssen; Heiko Hermeking
Journal:  Methods Mol Biol       Date:  2021

3.  Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2.

Authors:  Devin T Worster; Tobias Schmelzle; Nicole L Solimini; Eric S Lightcap; Bjorn Millard; Gordon B Mills; Joan S Brugge; John G Albeck
Journal:  Sci Signal       Date:  2012-03-06       Impact factor: 8.192

4.  The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis.

Authors:  Eileen L Heinrich; Tonya C Walser; Kostyantyn Krysan; Elvira L Liclican; Jeanette L Grant; Nicole L Rodriguez; Steven M Dubinett
Journal:  Cancer Microenviron       Date:  2011-09-16

Review 5.  MicroRNAs in mutagenesis, genomic instability, and DNA repair.

Authors:  Dan-Avi Landau; Frank J Slack
Journal:  Semin Oncol       Date:  2011-12       Impact factor: 4.929

Review 6.  Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy.

Authors:  Lin-hui Liang; Xiang-huo He
Journal:  Acta Pharmacol Sin       Date:  2011-09-12       Impact factor: 6.150

7.  PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.

Authors:  Kostyantyn Krysan; Rebecca Kusko; Tristan Grogan; James O'Hearn; Karen L Reckamp; Tonya C Walser; Edward B Garon; Marc E Lenburg; Sherven Sharma; Avrum E Spira; David Elashoff; Steven M Dubinett
Journal:  Mol Cancer Res       Date:  2014-01-27       Impact factor: 5.852

Review 8.  Noncoding RNAs in DNA repair and genome integrity.

Authors:  Guohui Wan; Yunhua Liu; Cecil Han; Xinna Zhang; Xiongbin Lu
Journal:  Antioxid Redox Signal       Date:  2013-09-18       Impact factor: 8.401

Review 9.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

10.  MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma.

Authors:  Z-X Yan; L-L Wu; K Xue; Q-L Zhang; Y Guo; M Romero; C Leboeuf; A Janin; S-J Chen; L Wang; W-L Zhao
Journal:  Leukemia       Date:  2013-10-09       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.